International Journal of Infectious Diseases

Papers
(The H4-Index of International Journal of Infectious Diseases is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts584
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients495
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis450
Role of favipiravir in the treatment of COVID-19301
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa300
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis290
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates281
Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples279
Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis247
Factors affecting perceived effectiveness of COVID-19 prevention measures among Filipinos during Enhanced Community Quarantine in Luzon, Philippines: Integrating Protection Motivation Theory and exten243
COVID-19 and healthcare workers: A systematic review and meta-analysis237
Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020233
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome225
COVID-19: Poor outcomes in patients with zinc deficiency209
Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers208
Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients205
Nutritional status of patients with COVID-19193
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial193
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa186
The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB184
Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study181
Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible175
An analysis of COVID-19 vaccine sentiments and opinions on Twitter175
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review168
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness165
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings163
Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website157
Side effects and perceptions following Sinopharm COVID-19 vaccination156
Mask use, risk-mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia, the UK and USA: A cross-sectional survey146
Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention143
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in gl134
An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination124
Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis114
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14108
Possible aerosol transmission of COVID-19 associated with an outbreak in an apartment in Seoul, South Korea, 2020107
Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis105
Therapeutic plasma exchange in adults with severe COVID-19 infection100
Africa’s low COVID-19 mortality rate: A paradox?100
Mast cell activation symptoms are prevalent in Long-COVID99
Asymptomatic hypoxia in COVID-19 is associated with poor outcome97
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review96
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 202194
Main differences between the first and second waves of COVID-19 in Madrid, Spain94
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings93
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients92
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic92
Mental health crisis under COVID-19 pandemic in Hong Kong, China87
Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs87
Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia84
COVID-19 infection among healthcare workers in a national healthcare system: The Qatar experience83
Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness82
Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients82
Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry82
Characteristics of healthcare workers infected with COVID-19: A cross-sectional observational study81
Marburg virus disease: A summary for clinicians80
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate78
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination78
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany77
Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors76
Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development76
Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review76
Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report73
The incubation period of COVID-19: A meta-analysis72
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab72
Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples72
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count71
Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic71
Antibody-dependent enhancement of coronavirus71
Analysis of the predictive factors for a critical illness of COVID-19 during treatment － relationship between serum zinc level and critical illness of COVID-19 −70
Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs69
Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis69
Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control69
0.044713973999023